Jury investor panel member     

Brigitte Drees

Brigitte Drees  | CEO | Pivot Park

Since 2018 Brigitte is CEO of Pivot Park. Under her guidance Pivot Park has more than doubled in size. With more than 60 companies and 1250 professionals and still growing, the science park is a hub for startups and scaleups in the biopharma industry and a fixed value within the Dutch LS&H community.

With 15+ years of supervisory board experience she is currently board member and chair of the audit committee at De Wever (Tilburg) and member of the board of the Talentencampus (Oss). As coordinator and co-founder of PharmaNL, she and her co-board members are committed to investing in shared pharma development infrastructure and lifelong learning within the Netherlands.


About Pivot Park

Europe's foremost biopharmaceutical campus  

Pivot Park is the hub for companies and knowledge institutes in the biopharma industry. Over 1,000 people work at the campus at 60 start-ups, scale-ups and established companies specialized in transformational drug discoveries.  

 Pivot Park offers sustainable real estate, facilities and services, gateways to knowledge, access to entrepreneurial expertise and a dynamic community. Pivot Park in Oss has everything that is required to develop Europe's foremost biopharmaceutical campus for a community that will together improve global health.   

Learn more at www.pivotpark.com  

Powered by:
Hyphen Projects   

    Connect     

Join Global Investor Forum

Privacy Policy
Terms & Conditions 
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 

                                    

          Register here
 
© Copyright 2023 by Hyphen Projects